You Position: Home > Paper
Differential expressions of lipid metabolism related genes in the liver of young apoE knockout mice
( views:362, downloads:44 )
- Author:
- No author available
- Journal Title:
- ACTA PHYSIOLOGICA SINICA
- Issue:
- 1
- DOI:
- 10.3321/j.issn:0371-0874.2008.01.008
- Key Word:
- apoE基凶缺失小鼠;动脉粥样硬化;脂代谢相关基因;肝脏;RT-PCR
Abstract： 本文旨在分析脂代谢相关基因在载脂蛋白E(apolipoprotein E,apoE)基因缺失(apoE-/-)幼龄小鼠肝脏中的表达特征及其与血脂紊乱和动脉粥样硬化(atherosclerosis,AS)早期病变的关系.利用半定量RT-PCR和荧光实时定量RT-PCR技术,分析14 d龄、1、2和3月龄apoE-/-小鼠及同龄野生型(wild type,WT)小鼠肝脏脂代谢相关基因的表达,并进行血生化指标及主动脉病理形态学榆测.apo-/-小鼠肝脏中apoAI、apoAIV表达在14d龄时即发生显著变化(P<0.05);在1月龄时apoB10G表达较同龄WT小鼠明显上调(P＜0.05);apoA V表达则在2月龄时较同龄WT小鼠上调(P＜0.05),此时可观察到apoE-/-小鼠主动脉内膜出现AS早期病变;Faf/CD36和Angptl 3表达在3月龄时较同龄WT小鼠上调(P＜0.05);实验中检测的其它基因的mRNA表达与同龄WT小鼠相比无显著性差异.apoE-/-小鼠血清总胆同醇、甘油三酯、低密度脂蛋白胆固醇和高密度脂蛋白胆固醇含量均高于同龄WT小鼠,并随年龄增长而升高.apoE-/-小鼠和同龄WT小鼠血清中apoB100蛋白浓度在14 d龄到3月龄问变化趋势与其在肝脏中mRNA表达及血清中低密度脂蛋白胆崮醇含量变化趋势基本一致.上述部分脂代谢相关基因表达在幼龄小鼠即发生改变,与血脂紊乱以及主动脉AS病变发生发展过程呈正相关,说明其可能在幼龄小鼠脂质代谢紊乱发生过程中起重要作用,从而引起动脉内皮细胞功能改变乃至AS早期病变的发生.
- [1]孙文夏,施育平,金晓蕾,等.三基因突变小鼠血脂代谢及动脉粥样硬化早期病变特征[J].2004,(11).
- [2]王保华,欧阳静萍,刘永明,等.当归对高脂血清所致ECV304细胞损伤的保护作用[J].2001,(3).
- [3]马布依阿,郭静萱,赵一鸣.血浆载脂蛋白A-Ⅳ水平与冠心病关系的研究[J].2001,(3).
- [4]S H, Zhang,R L, Reddick,J A, Piedrahita,etc.Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.[J].1992,258.
- [5]Liang Y,Liang GS,Cao GQ,etc.Liver X receptors (LXRs) regulate apolipoprotein AIV-implications of the antiatherosclerotic effect of LXR agonists[J].2004,18(8).
- [6]Genest J.Lipoprotein disorders and cardiovascular risk.[J].2003,26(2).
- [7]Larsson SL,Skogsberg J,Bjokegren J.The low density lipoprotein receptor prevents secretion of dense apoB100-containing lipoproteins from the liver.[J].2004,279(2).
- [8]Kaplan R,Zhang T,Hernandez M,etc.Regulation of the angiopoietin-like protein 3 gene by LXR.[J].2003,44(1).
- [9]Foger B,Santamarina Fojo-S,Koch CA,etc.Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice.[J].1999,274(52).
- [10]O, Barbier,I Pineda, Torra,Y, Duguay,etc.Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis.[J].2002,22(5).
- [11]M S, Brown,J L, Goldstein.A receptor-mediated pathway for cholesterol homeostasis.[J].1986,232(4746).
- [12]Tso P,Qin X,Hui DY,etc.Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation.[J].1998,274(5 Pt.2).
- [13]R, Ross.The pathogenesis of atherosclerosis: a perspective for the 1990s.[J].1993,362(6423).
- [14]Kluger M,Pennacchio LA,Fabig N,etc.Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase[J].2005,280(22).
- [15]Bocher V,Staels B,Millatt LJ,etc.Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis.[J].2003,1631(2).
- [16]Mezdour H,Maeda N,Sullivan PM,etc.ApoB-48 and apoB-100 differentially influence the expression of type-III hyperlipoproteinemia in APOE*2 mice.[J].2002,43(9).